4156 Federal Register / Vol. 71, No. 16 / Wednesday, January 25, 2006 / Notices 

Name of Committee: National Institute of 

Mental Health Special Emphasis Panel; 

ITV—Schizophrenia and Aging. 

Date:≤ February 15, 2006. 

Time: 8:30 to 5 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: Hyatt Regency Bethesda, One 

Bethesda Metro Center, 7400 Wisconsin 

Avenue, Bethesda, MD 20814. 

Contact Person: Tracy Waldeck, PhD, 

Scientific Review Administrator, Division of 

Extramural Activities, National Institute of 

Mental Health, NIH, Neuroscience Center, 

6001 Executive Blvd., Room 6132, MSC 9608, 

Bethesda, MD 20852–9609. 301/435–0322. 

waldeckt@mail.nih.gov. 

(Catalogue of Federal Domestic Assistance 

Program Nos. 93.242, Mental Health Research 

Grants; 93.281, Scientist Development 

Award, Scientist Development Award for 

Clinicians, and Research Scientist Award; 

93.282, Mental Health National Research 

Service Awards for Research Training, 

National Institutes of Health, HHS) 

Dated: January 17, 2006. 

Anna Snouffer, 

Acting Director, Office of Federal Advisory 

Committee Policy. 

[FR Doc. 06–690 Filed 1–24–06; 8:45 am] 

BILLING CODE 4140–01–M 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

National Institutes of Health 

National Institute of Allergy and 

Infectious Diseases; Notice of Closed 

Meetings 

Pursuant to section 10(d) of the 

Federal Advisory Committee Act, as 

amended (5 U.S.C. Appendix 2), notice 

is hereby given of the following 

meetings. 

The meetings will be closed to the 

public in accordance with the 

provisions set forth in sections 

552b(c)(4) and 552b(c)(6), Title 5 U.S.C., 

as amended. The grant applications and 

the discussions could disclose 

confidential trade secrets or commerical 

property such as patentable material, 

and personal information concerning 

individuals associated with the grant 

applications, the disclosure of which 

would constitute a clearly unwarranted 

invasion of personal privacy. 

Name of Committee: National Institute of 

Allergy and Infectious Diseases Special 

Emphasis Panel, Integrated Preclinical/ 

Clinical AIDS Vaccine Development 

(IPCAVD). 

Date: February 15, 2006. 

Time: 1 p.m. to 5 p.m. 

Agenda: To review and evaluate 

cooperative agreement applications. 

Place: National Institutes of Health, 6700B 

Rockledge Drive, Room 3129, Bethesda, MD 

20892, (Telephone Conference Call). 

Contact Person: Eleazar Cohen, PhD, 

Scientific Review Administrator, Scientific 

Review Program, Division of Extramural 

Activities, NIAID/NIH/DHHS, Room 3129, 

6700 B Rockledge Drive, Bethesda, MD 

20892, (301) 435–3564, ec17w@nih.gov. 

Name of Committee: National Institute of 

Allergy and Infectious Diseases Special 

Emphasis Panel, Units for HIV/AIDS Clinical 

Trials Network (2). 

Date: February 15, 2006. 

Time: 12 p.m. to 6 p.m. 

Agenda: To review and evaluate 

cooperative agreement applications. 

Place: National Institutes of Health, 

Rockledge 6700, 6700B Rockledge Drive, 

Room 1202, Bethesda, MD 20817, (Telephone 

Conference Call). 

Contact Person: Kenneth E. Santora, PhD, 

Scientific Review Administrator, Scientific 

Review Program, Division of Extramural 

Activities, NIH/NIAID/DHHS, 6700B 

Rockledge Drive, MSC 7616, Bethesda, MD 

20892–7616, (301) 496–2550, 

ks216i@nih.gov. 

Name of Committee: National Institute of 

Allergy and Infectious Diseases Special 

Emphasis Panel, Units for HIV/AIDS Clinical 

Trials Network (8). 

Date: February 16, 2006. 

Time: 9 a.m. to 4 p.m. 

Agenda: To review and evaluate 

cooperative agreement applications. 

Place: National Institutes of Health, 

Rockledge 6700, 6700B Rockledge Drive, 

Bethesda, MD 20817, (Telephone Conference 

Call). 

Contact Person: Brenda Lange-Gustafson, 

PhD, Scientific Review Administrator, 

NIAID, DEA, Scientific Review Program, 

Room 2217, 6700–B Rockledge Drive, MSC–

7616, Bethesda, MD 20892–7616, (301) 496–

2550, bgustafson@niaid.nih.gov. 

Name of Committee: National Institute of 

Allergy and Infectious Diseases Special 

Emphasis Panel, Unit for HIV/AIDS Clinical 

Trials Network (14)–ZAL1–TP–A–M3. 

Date: February 17, 2006. 

Time: 10 a.m. to 4 p.m. 

Agenda: To review and evaluate 

cooperative agreement applications. 

Place: National Institutes of Health, 6700 

B, Rockledge Drive, 3143, Bethesda, MD 

20892, (Telephone Conference Call). 

Contact Person: Thames E. Pickett, PhD, 

Scientific Review Administrator, Scientific 

Review Program, Division of Extramural 

Activities, NIH/NIAID/DHHS, 6700B 

Rockledge Drive, MSC 7616, Bethesda, MD 

20892–7616, 301–496–2550, 

pickettte@niaid.nih.gov. 

Name of Committee: National Institute of 

Allergy and Infectious Diseases Special 

Emphasis Panel, Units for HIV/AIDS Clinical 

Trials Network (Sep 10). 

Date: February 21, 2006. 

Time: 12 p.m. to 6 p.m. 

Agenda: To review and evaluate 

cooperative agreement applications. 

Place: National Institutes of Health, 

Rockledge 6700, 6700B Rockledge Drive, 

Bethesda, MD 20817, (Telephone Conference 

Call). 

Contact Person: Darren D Sledjeski, PhD, 

Scientific Review Administrator, NIAID, 

DEA, Scientific Review Program, Room 3253, 

6700B Rockledge Drive, MSC–7616, 

Bethesda, MD 20892–7616, 301–451–2638. 

(Catalogue of Federal Domestic Assistance 

Program Nos. 93.855, Allergy, Immunology, 

and Transplantation Research; 93.856, 

Microbiology and Infectious Diseases 

Research, National Institutes of Health, HHS) 

Dated: January 18, 2006. 

Anna Snouffer, 

Acting Director, Office of Federal Advisory 

Committee Policy. 

[FR Doc. 06–693 Filed 1–24–06; 8:45 am] 

BILLING CODE 4140–01–M 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

National Institutes of Health 

National Institute of Allergy and 

Infectious Diseases; Notice of Closed 

Meetings 

Pursuant to section 10(d) of the 

Federal Advisory Committee Act, as 

amended (5 U.S.C. Appendix 2), notice 

is hereby given of the following 

meetings. 

The meetings will be closed to the 

public in accordance with the 

provisions set forth in sections 

552b(c)(4) and 552b(c)(6), Title 5 U.S.C., 

as amended. The grant applications and 

the discussions could disclose 

confidential trade secrets or commercial 

property such as patentable material, 

and personal information concerning 

individuals associated with the grant 

applications, the disclosure of which 

would constitute a clearly unwarranted 

invasion of personal privacy. 

Name of Committee: National Institute of 

Allergy and Infectious Diseases Special 

Emphasis Panel. Units for HIV/AIDS Clinical 

Trials Network (3)—ZAI1–SR–A–M2. 

Date: February 13, 2006. 

Time: 11 a.m. to 6 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: National Institutes of Health, 

Rockledge 6700, 6700B Rockledge Drive, 

Bethesda, MD 20817. (Telephone Conference 

Call). 

Contact Person: Stefani T. Rudnick, Ph.D., 

Scientific Review Administrator, Scientific 

Review Program, Division of Extramural 

Activities, National Institutes of Health/ 

NIAID, 6700B Rockledge Drive, MSC 7616, 

Bethesda, MD 20892–7616. 301–496–2500. 

srudnick@niaid/nih/gov. 

Name of Committee: National Institute of 

Allergy and Infectious Diseases Special 

Emphasis Panel. Partnerships to Develop 

Tools to Evaluate Women’s Health. 

Date: February 17, 2006. 

Time: 8 a.m. to 5 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: Hyatt Regency Bethesda, One 

Bethesda Metro Center, Bethesda, MD 20814. 


wwhite on PROD1PC61 with NOTICES